| EX0891 HEPATOCELLULAR CARCINOMA (HCC) PANEL |
| Specimen: |
3 mL (2 mL min.) serum from 1 SST AND 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Give brief clinical history. Hemolysed specimens are not acceptable. |
| Stability: |
| Room |
Refrigerated |
Frozen |
| 2 hrs |
24 hrs |
NA |
|
| Method: |
Spectrophotometry, Electrical Impedance, VCS, Chemiluminescent Immunoassay, IFCC |
| Comment: |
|
| Report: |
Contact us to know the TAT. |
| Usage: |
Regular screening for Hepatocellular carcinoma (HCC) in Chronic hepatitis patients increases the possibility of detection of HCC at an earlier stage and therefore improves the chances of radical treatment. It is recommended to measure two or more different tumor markers (AFP, DCP/ PIVKA II, or AFP L3) along with Ultrasound for the diagnosis of HCC at an early stage. |
| Doctor Specialty: |
Oncologist, Gastroenterologist |
| Disease: |
Disorders of Liver |
| Components: |
*CBC *AST (SGOT) *ALT (SGPT) *AST:ALT ratio *GGTP *Bilirubin, Total, Direct & Indirect *Protein,Total *Albumin *A:G ratio *Alkaline Phosphatase *LDH *AFP *DCP/PIVKA II |
| Courier Charges: |
|
| Home Collection: |
Available (*T&C Apply) |
| Department: |
Biochemistry |
| Pre Test Information: |
Give brief clinical history. |
Reviews
There are no reviews yet.